In8bio
Price & Volume
Stats
See more52W Range | $0.13-$1.74 |
Market Cap | $13.8M |
Shares Short | 478,257 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.57 |
News
See moreYahoo Finance • 2 months ago
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
Yahoo Finance • 2 months ago
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Yahoo Finance • 2 months ago
IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
Yahoo Finance • 3 months ago
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
About
CEO | Mr. Tai-Wei Ho |
CFO | Mr. Patrick McCall CPA |
Address | 350 5th Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
